These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34409570)

  • 1. The Costs of Creatinine Testing in the Context of a HIV Pre-Exposure Prophylaxis Demonstration Project in Eswatini.
    Kohler S; Ndungwani R; Burgert M; Sibandze D; Matse S; Hettema A
    AIDS Behav; 2022 Mar; 26(3):728-738. PubMed ID: 34409570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human resource needs and costs for HIV pre-exposure prophylaxis provision in nurse-led primary care in Eswatini and opportunities for task sharing.
    Kohler S; Dalal S; Hettema A; Matse S; Bärnighausen T; Paul N
    Hum Resour Health; 2022 Oct; 20(1):75. PubMed ID: 36274118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya.
    Roberts DA; Barnabas RV; Abuna F; Lagat H; Kinuthia J; Pintye J; Bochner AF; Forsythe S; Gomez GB; Baeten JM; John-Stewart G; Levin C
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25296. PubMed ID: 31328443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low costs and opportunities for efficiency: a cost analysis of the first year of programmatic PrEP delivery in Kenya's public sector.
    Peebles K; Mugwanya KK; Irungu E; Odoyo J; Wamoni E; Morton JF; Ngure K; Bukusi EA; Mugo NR; Masyuko S; Mukui I; Baeten JM; Barnabas RV;
    BMC Health Serv Res; 2021 Aug; 21(1):823. PubMed ID: 34399736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out-of-pocket Expenses and Time Spent on Clinic Visits Among HIV Pre-exposure Prophylaxis Users and Other Clinic Attendees in Eswatini.
    Kohler S; Dalal S; Hettema A; Matse S; Bärnighausen T; Paul N
    AIDS Behav; 2023 Apr; 27(4):1222-1233. PubMed ID: 36219271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative accounts of PrEP discontinuation from the general population in Eswatini.
    Bärnighausen K; Geldsetzer P; Matse S; Hettema A; Hughey AB; Dlamini P; Mavuso M; Fakudze D; Kahn K; Bärnighausen T; McMahon SA
    Cult Health Sex; 2021 Sep; 23(9):1198-1214. PubMed ID: 32633617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
    Suraratdecha C; Stuart RM; Manopaiboon C; Green D; Lertpiriyasuwat C; Wilson DP; Pavaputanon P; Visavakum P; Monkongdee P; Khawcharoenporn T; Tharee P; Kittinunvorakoon C; Martin M
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya.
    Wanga V; Peebles K; Obiero A; Mogaka F; Omollo V; Odoyo JB; Morton JF; Bukusi EA; Celum C; Baeten JM; Barnabas RV
    PLoS One; 2021; 16(4):e0249625. PubMed ID: 33857195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
    van Vliet MM; Hendrickson C; Nichols BE; Boucher CA; Peters RP; van de Vijver DA
    J Int AIDS Soc; 2019 Dec; 22(12):e25427. PubMed ID: 31855323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrEP uptake and delivery setting preferences among clients visiting six healthcare facilities in Eswatini.
    Inghels M; Kim HY; Tanser F; Hettema A; McMahon SA; Oldenburg CE; Matse S; Kohler S; Geldsetzer P; Bärnighausen T
    AIDS Behav; 2022 Oct; 26(10):3345-3355. PubMed ID: 35429309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of HIV pre-exposure prophylaxis in Japan.
    Mizushima D; Nagai Y; Mezzio D; Harada K; Piao Y; Barnieh L; El Moustaid F; Cawson M; Taniguchi T
    J Med Econ; 2023; 26(1):886-893. PubMed ID: 37421417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "We know this will be hard at the beginning, but better in the long term": understanding PrEP uptake in the general population in Eswatini.
    Bärnighausen K; Matse S; Hughey AB; Hettema A; Bärnighausen TW; McMahon SA
    AIDS Care; 2020 Feb; 32(2):267-273. PubMed ID: 31437021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Community-Based, Mobile HIV-Care, Peer-Delivered Linkage Case Management in Manzini Region, Eswatini.
    Suraratdecha C; MacKellar D; Hlophe T; Dlamini M; Ujamaa D; Pals S; Dube L; Williams D; Byrd J; Mndzebele P; Behel S; Pathmanathan I; Mazibuko S; Tilahun E; Ryan C
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of HIV services in Nigeria: Determinants of unit cost variation of HIV counseling and testing and prevention of mother-to-child transmission interventions.
    Bautista-Arredondo S; La Hera-Fuentes G; Contreras-Loya D; Kwan A; Van Buren SJ; Amanze OO; Atobatele A; Adeyemi A; Abatta E; Ogungbemi KM; Sosa-Rubí SG
    PLoS One; 2018; 13(9):e0201706. PubMed ID: 30192765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa.
    Simeon K; Sharma M; Dorward J; Naidoo J; Dlamini N; Moodley P; Samsunder N; Barnabas RV; Garrett N; Drain PK
    PLoS One; 2019; 14(10):e0223669. PubMed ID: 31618220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis.
    Vogelzang M; Terris-Prestholt F; Vickerman P; Delany-Moretlwe S; Travill D; Quaife M
    J Acquir Immune Defic Syndr; 2020 Jun; 84(2):173-181. PubMed ID: 32141959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
    Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M
    J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.